Knowledge Leaders Capital, LLC Gilead Sciences, Inc. Transaction History

Knowledge Leaders Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$76.01 - $86.7 $31,468 - $35,893	-414 Reduced 3.02%	13,316 $1.03 Million
Q1 2023 May 04, 2023	SELL	$77.31 - $88.08 $32,006 - $36,465	-414 Reduced 2.93%	13,730 $1.14 Million
Q4 2022 Feb 07, 2023	BUY	$62.32 - $89.47 $503,483 - $722,828	8,079 Added 133.21%	14,144 $1.21 Million
Q3 2022 Nov 02, 2022	SELL	$59.54 - $68.01 $20,005 - $22,851	-336 Reduced 5.25%	6,065 $374,000
Q2 2022 Aug 03, 2022	SELL	$57.72 - $65.01 $38,499 - $43,361	-667 Reduced 9.44%	6,401 $396,000
Q4 2021 Feb 02, 2022	BUY	$64.88 - $73.64 $44,377 - $50,369	684 Added 10.71%	7,068 $513,000
Q3 2021 Nov 04, 2021	BUY	$67.69 - $73.03 $5,144 - $5,550	76 Added 1.2%	6,384 $446,000
Q2 2021 Aug 09, 2021	BUY	$63.47 - $69.35 $4,823 - $5,270	76 Added 1.22%	6,308 $434,000
Q2 2020 Aug 12, 2020	BUY	$72.34 - $84.0 $450,822 - $523,488	6,232 New	6,232 $479,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Knowledge Leaders Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Knowledge Leaders Capital, LLC with notifications on news.